| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.533 | 0.04 | 0.533 | Transcription factor NF kappa B inhibitor | 0.447 0.054 DBMET03744 0.447 0.054 DBMET03743 | ||
| 0.494 | 0.002 | 0.494 | Acetylcholine M3 receptor agonist | 0.171 0.01 DBMET03744 0.171 0.01 DBMET03743 | ||
| 0.462 | 0.003 | 0.462 | Farnesyltransferase inhibitor | 0.376 0.003 DBMET03744 0.376 0.003 DBMET03743 0.453 0.003 DBMET03745 | ||
| 0.457 | 0.002 | 0.457 | CYP2A6 inhibitor | 0.14 0.019 DBMET03744 0.14 0.019 DBMET03743 | ||
| 0.345 | 0.004 | 0.345 | Acetylcholine M4 receptor antagonist | 0.118 0.019 DBMET03744 0.118 0.019 DBMET03743 | ||
| 0.341 | 0.009 | 0.341 | Acetylcholine M1 receptor antagonist | 0.179 0.053 DBMET03744 0.179 0.053 DBMET03743 | ||
| 0.388 | 0.069 | 0.388 | Immunosuppressant | 0.243 0.153 DBMET03744 0.243 0.153 DBMET03743 0.294 0.119 DBMET03745 | ||
| 0.307 | 0.004 | 0.307 | Acetylcholine muscarinic agonist | 0.062 0.033 DBMET03744 0.062 0.033 DBMET03743 | ||
| 0.284 | 0.004 | 0.284 | Acetylcholine M1 receptor agonist | 0.048 0.027 DBMET03744 0.048 0.027 DBMET03743 | ||
| 0.264 | 0.005 | 0.264 | Acetylcholine M2 receptor antagonist | 0.078 0.031 DBMET03744 0.078 0.031 DBMET03743 | ||
| 0.259 | 0.019 | 0.259 | Acetylcholine antagonist | 0.121 0.07 DBMET03744 0.121 0.07 DBMET03743 | ||
| 0.26 | 0.019 | 0.26 | Cholinergic antagonist | 0.123 0.071 DBMET03744 0.123 0.071 DBMET03743 | ||
| 0.231 | 0.01 | 0.231 | Acetylcholine agonist | |||
| 0.223 | 0.003 | 0.269 | Geranylgeranyltransferase I inhibitor | 0.176 0.003 DBMET03744 0.176 0.003 DBMET03743 0.269 0.002 DBMET03745 | DBMET03745 | |
| 0.222 | 0.002 | 0.222 | Acetylcholine M5 receptor agonist | 0.108 0.015 DBMET03744 0.108 0.015 DBMET03743 | ||
| 0.253 | 0.048 | 0.253 | RNA-directed DNA polymerase inhibitor | 0.233 0.062 DBMET03744 0.233 0.062 DBMET03743 | ||
| 0.217 | 0.02 | 0.217 | Acetylcholine muscarinic antagonist | 0.131 0.057 DBMET03744 0.131 0.057 DBMET03743 | ||
| 0.193 | 0.005 | 0.193 | Acetylcholine M5 receptor antagonist | |||
| 0.187 | 0.005 | 0.187 | Histamine H3 receptor agonist | 0.108 0.006 DBMET03744 0.108 0.006 DBMET03743 | ||
| 0.217 | 0.039 | 0.217 | Cholinergic | |||
| 0.245 | 0.069 | 0.349 | DNA synthesis inhibitor | 0.349 0.03 DBMET03744 0.349 0.03 DBMET03743 0.215 0.101 DBMET03745 | DBMET03743 | |
| 0.192 | 0.019 | 0.254 | Beta amyloid protein antagonist | 0.254 0.008 DBMET03744 0.254 0.008 DBMET03743 | DBMET03743 | |
| 0.171 | 0.022 | 0.321 | Antineoplastic alkaloid | 0.321 0.002 DBMET03744 0.321 0.002 DBMET03743 | DBMET03743 | |
| 0.289 | 0.144 | 0.289 | Antibacterial | 0.261 0.167 DBMET03745 | ||
| 0.252 | 0.124 | 0.34 | Cholesterol antagonist | 0.34 0.069 DBMET03744 0.34 0.069 DBMET03743 0.327 0.075 DBMET03745 | DBMET03743 | |
| 0.142 | 0.014 | 0.142 | Aromatase inhibitor | 0.106 0.02 DBMET03744 0.106 0.02 DBMET03743 | ||
| 0.126 | 0.003 | 0.126 | Acetylcholine M4 receptor agonist | |||
| 0.152 | 0.04 | 0.575 | Topoisomerase I inhibitor | 0.575 0.003 DBMET03744 0.575 0.003 DBMET03743 | DBMET03743 | |
| 0.159 | 0.057 | 0.224 | Cell wall synthesis inhibitor | 0.154 0.062 DBMET03744 0.154 0.062 DBMET03743 0.224 0.022 DBMET03745 | DBMET03745 | |
| 0.151 | 0.072 | 0.151 | GABA C receptor rho-2 antagonist | 0.133 0.101 DBMET03744 0.133 0.101 DBMET03743 | ||
| 0.082 | 0.012 | 0.082 | Acetylcholine M2 receptor agonist | 0.066 0.023 DBMET03744 0.066 0.023 DBMET03743 | ||
| 0.158 | 0.089 | 0.158 | ATPase inhibitor | 0.148 0.105 DBMET03744 0.148 0.105 DBMET03743 | ||
| 0.105 | 0.041 | 0.105 | Alpha 2d adrenoreceptor antagonist | 0.097 0.055 DBMET03744 0.097 0.055 DBMET03743 | ||
| 0.162 | 0.102 | 0.361 | Anesthetic general | 0.178 0.088 DBMET03744 0.178 0.088 DBMET03743 0.361 0.022 DBMET03745 | DBMET03745 | |
| 0.106 | 0.047 | 0.117 | Lanosterol 14 alpha demethylase inhibitor | 0.117 0.034 DBMET03744 0.117 0.034 DBMET03743 0.1 0.055 DBMET03745 | DBMET03743 | |
| 0.098 | 0.04 | 0.098 | Acetylcholine nicotinic antagonist | |||
| 0.101 | 0.043 | 0.101 | Phosphodiesterase I inhibitor | |||
| 0.181 | 0.127 | 0.201 | Peptidyltransferase inhibitor | 0.182 0.126 DBMET03744 0.182 0.126 DBMET03743 0.201 0.097 DBMET03745 | DBMET03745 | |
| 0.203 | 0.149 | 0.203 | 12-Lipoxygenase inhibitor | |||
| 0.117 | 0.064 | 0.153 | Microtubule formation inhibitor | 0.153 0.036 DBMET03744 0.153 0.036 DBMET03743 | DBMET03743 | |
| 0.172 | 0.12 | 0.172 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.069 | 0.025 | 0.069 | Protein 50S ribosomal subunit inhibitor | 0.049 0.041 DBMET03744 0.049 0.041 DBMET03743 | ||
| 0.087 | 0.044 | 0.087 | T cell inhibitor | |||
| 0.07 | 0.029 | 0.07 | Phosphodiesterase 1C inhibitor | |||
| 0.069 | 0.032 | 0.069 | Acetylcholine M3 receptor antagonist | |||
| 0.062 | 0.03 | 0.062 | Bombesin 3 receptor antagonist | 0.056 0.038 DBMET03744 0.056 0.038 DBMET03743 | ||
| 0.207 | 0.179 | 0.298 | Sodium/bile acid cotransporter inhibitor | 0.298 0.081 DBMET03744 0.298 0.081 DBMET03743 0.298 0.081 DBMET03745 | DBMET03745 | |
| 0.031 | 0.009 | 0.08 | Geranylgeranyltransferase inhibitor | 0.021 0.016 DBMET03744 0.021 0.016 DBMET03743 0.08 0.004 DBMET03745 | DBMET03745 | |
| 0.059 | 0.042 | 0.059 | Phosphodiesterase 1A inhibitor | |||
| 0.16 | 0.143 | 0.16 | Vasodilator | |||
| 0.057 | 0.045 | 0.106 | Bombesin 1 receptor agonist | 0.106 0.016 DBMET03744 0.106 0.016 DBMET03743 | DBMET03743 | |
| 0.09 | 0.079 | 0.193 | GABA C receptor agonist | 0.101 0.066 DBMET03744 0.101 0.066 DBMET03743 0.193 0.022 DBMET03745 | DBMET03745 | |
| 0.068 | 0.059 | 0.068 | Phosphodiesterase VIII inhibitor | |||
| 0.129 | 0.121 | 0.129 | Nitric oxide antagonist | 0.129 0.12 DBMET03744 0.129 0.12 DBMET03743 | ||
| 0.055 | 0.049 | 0.055 | Phosphodiesterase 1B inhibitor | |||
| 0.034 | 0.03 | 0.034 | Somatostatin 4 agonist | |||
| 0.021 | 0.018 | 0.021 | Motilin receptor agonist | |||
| 0.039 | 0.037 | 0.039 | DNA gyrase subunit A inhibitor | |||
| 0.028 | 0.027 | 0.028 | Potassium channel (Inward rectifier) 1 blocker | |||
| 0.012 | 0.011 | 0.012 | Antibiotic Macrolide-like | |||
| 0.125 | 0.147 | 0.152 | Ca2+-transporting ATPase inhibitor | 0.152 0.039 DBMET03744 0.152 0.039 DBMET03743 0.15 0.043 DBMET03745 | DBMET03743 | |
| 0.17 | 0.201 | 0.21 | Tyrosine 3 hydroxylase inhibitor | 0.21 0.119 DBMET03745 | DBMET03745 | |
| 0.024 | 0.057 | 0.056 | Carboxypeptidase B inhibitor | 0.056 0.005 DBMET03745 | DBMET03745 | |
| 0.1 | 0.136 | 0.45 | Diuretic | 0.45 0.01 DBMET03745 | DBMET03745 | |
| 0.014 | 0.05 | 0.024 | Bombesin agonist | 0.024 0.012 DBMET03745 | DBMET03745 | |
| 0.06 | 0.098 | 0.113 | Histamine N-methyltransferase inhibitor | 0.113 0.035 DBMET03745 | DBMET03745 | |
| 0.011 | 0.049 | 0.019 | Bombesin 3 receptor agonist | 0.019 0.012 DBMET03745 | DBMET03745 | |
| 0.003 | 0.047 | 0.02 | Carboxypeptidase B2 inhibitor | 0.02 0.004 DBMET03745 | DBMET03745 | |
| 0.045 | 0.09 | 0.07 | Ca(v)3.2 blocker | 0.07 0.023 DBMET03745 | DBMET03745 | |
| 0.181 | 0.227 | 0.195 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.195 0.181 DBMET03744 0.195 0.181 DBMET03743 | DBMET03743 | |
| 0.179 | 0.237 | 0.243 | GABA C receptor rho-3 antagonist | 0.243 0.16 DBMET03745 | DBMET03745 | |
| 0.104 | 0.164 | 0.198 | Psychostimulant | 0.198 0.081 DBMET03745 | DBMET03745 | |
| 0.036 | 0.105 | 0.07 | Thromboxane synthase inhibitor | 0.07 0.018 DBMET03745 | DBMET03745 | |
| 0.113 | 0.185 | 0.217 | Lipocortins synthesis antagonist | 0.217 0.047 DBMET03744 0.217 0.047 DBMET03743 0.141 0.119 DBMET03745 | DBMET03743 | |
| 0.04 | 0.117 | 0.09 | Polo-like kinase-2 inhibitor | 0.09 0.035 DBMET03745 | DBMET03745 | |
| 0.03 | 0.108 | 0.069 | Glucagon-like peptide 1 agonist | 0.069 0.042 DBMET03745 | DBMET03745 | |
| 0.061 | 0.15 | 0.094 | Anabolic | 0.094 0.071 DBMET03744 0.094 0.071 DBMET03743 | DBMET03743 | |
| 0.03 | 0.121 | 0.127 | Phosphofructokinase-1 inhibitor | 0.127 0.023 DBMET03745 | DBMET03745 | |
| 0.055 | 0.149 | 0.088 | Expectorant | 0.088 0.085 DBMET03744 0.088 0.085 DBMET03743 | DBMET03743 | |
| 0.019 | 0.116 | 0.063 | Geranyltranstransferase inhibitor | 0.063 0.011 DBMET03745 | DBMET03745 | |
| 0.013 | 0.116 | 0.035 | Calcitonin receptor agonist | 0.035 0.023 DBMET03745 | DBMET03745 | |
| 0.017 | 0.122 | 0.123 | Ornithine carbamoyltransferase inhibitor | 0.123 0.012 DBMET03745 | DBMET03745 | |
| 0.032 | 0.138 | 0.067 | Histidine decarboxylase inhibitor | 0.067 0.054 DBMET03745 | DBMET03745 | |
| 0.018 | 0.123 | 0.063 | Adenosine deaminase inhibitor | 0.063 0.018 DBMET03745 | DBMET03745 | |
| 0.086 | 0.201 | 0.119 | DNA repair enzyme inhibitor | 0.119 0.075 DBMET03744 0.119 0.075 DBMET03743 | DBMET03743 | |
| 0.051 | 0.167 | 0.447 | Topoisomerase II inhibitor | 0.447 0.008 DBMET03744 0.447 0.008 DBMET03743 | DBMET03743 | |
| 0.009 | 0.128 | 0.029 | Lysine carboxypeptidase inhibitor | 0.029 0.017 DBMET03745 | DBMET03745 | |
| 0.025 | 0.146 | 0.068 | Antineoplastic antibiotic | 0.068 0.067 DBMET03744 0.068 0.067 DBMET03743 | DBMET03743 | |
| 0.029 | 0.158 | 0.045 | Bombesin 2 receptor antagonist | 0.045 0.042 DBMET03745 | DBMET03745 | |
| 0.141 | 0.273 | 0.198 | Insulysin inhibitor | 0.198 0.16 DBMET03745 | DBMET03745 | |
| 0.071 | 0.205 | 0.374 | Angiogenesis stimulant | 0.374 0.027 DBMET03745 | DBMET03745 | |
| 0.175 | 0.313 | 0.512 | Apoptosis agonist | 0.512 0.071 DBMET03744 0.512 0.071 DBMET03743 | DBMET03743 | |
| 0.093 | 0.235 | 0.22 | Platelet antagonist | 0.22 0.088 DBMET03745 | DBMET03745 | |
| 0.132 | 0.275 | 0.241 | Vasodilator, peripheral | 0.241 0.134 DBMET03745 | DBMET03745 | |
| 0.053 | 0.202 | 0.119 | Alkylator | 0.119 0.069 DBMET03744 0.119 0.069 DBMET03743 | DBMET03743 | |
| 0.129 | 0.286 | 0.257 | Antithrombotic | 0.257 0.12 DBMET03745 | DBMET03745 | |
| 0.043 | 0.203 | 0.431 | DNA intercalator | 0.431 0.006 DBMET03744 0.431 0.006 DBMET03743 | DBMET03743 | |
| 0.015 | 0.175 | 0.037 | Membrane dipeptidase inhibitor | 0.037 0.031 DBMET03745 | DBMET03745 | |
| 0.026 | 0.186 | 0.077 | Porphobilinogen synthase inhibitor | 0.077 0.049 DBMET03745 | DBMET03745 | |
| 0.106 | 0.266 | 0.34 | Hypoglycemic | 0.34 0.04 DBMET03745 | DBMET03745 | |
| 0.02 | 0.181 | 0.075 | Carbamoyl phosphate synthetase inhibitor | 0.075 0.031 DBMET03745 | DBMET03745 | |
| 0.024 | 0.186 | 0.044 | Glutamate (mGluR group III) antagonist | 0.044 0.029 DBMET03745 | DBMET03745 | |
| 0.023 | 0.186 | 0.051 | Glucose-6-phosphate isomerase inhibitor | 0.051 0.028 DBMET03745 | DBMET03745 | |
| 0.086 | 0.252 | 0.204 | Antiamyloidogenic | 0.204 0.097 DBMET03744 0.204 0.097 DBMET03743 | DBMET03743 | |
| 0.143 | 0.317 | 0.237 | Interleukin 2 agonist | 0.237 0.134 DBMET03745 | DBMET03745 | |
| 0.053 | 0.228 | 0.104 | Nav1.4 sodium channel blocker | 0.104 0.071 DBMET03745 | DBMET03745 | |
| 0.023 | 0.2 | 0.055 | Carbonic anhydrase stimulant | 0.055 0.047 DBMET03745 | DBMET03745 | |
| 0.091 | 0.273 | 0.205 | Antioxidant | 0.205 0.11 DBMET03745 | DBMET03745 | |
| 0.038 | 0.225 | 0.071 | Glutamate (mGluR6) antagonist | 0.071 0.038 DBMET03745 | DBMET03745 | |
| 0.057 | 0.248 | 0.101 | Adenylate kinase inhibitor | 0.101 0.066 DBMET03745 | DBMET03745 | |
| 0.002 | 0.195 | 0.015 | Angiotensin AT1B receptor antagonist | 0.015 0.008 DBMET03745 | DBMET03745 | |
| 0.016 | 0.208 | 0.103 | Argininosuccinate synthase inhibitor | 0.103 0.018 DBMET03745 | DBMET03745 | |
| 0.109 | 0.302 | 0.268 | Hypoxia-inducible factor 1 alpha inhibitor | 0.268 0.085 DBMET03744 0.268 0.085 DBMET03743 | DBMET03743 | |
| 0.016 | 0.21 | 0.082 | Alcohol oxidase inhibitor | 0.082 0.024 DBMET03745 | DBMET03745 | |
| 0.012 | 0.214 | 0.033 | Glutamate (mGluR3) antagonist | 0.033 0.032 DBMET03745 | DBMET03745 | |
| 0.004 | 0.217 | 0.018 | Angiotensin AT2 receptor antagonist | 0.018 0.017 DBMET03745 | DBMET03745 | |
| 0.044 | 0.258 | 0.111 | DNA polymerase I inhibitor | 0.111 0.076 DBMET03745 | DBMET03745 | |
| 0.004 | 0.222 | 0.021 | Angiotensin AT1A receptor antagonist | 0.021 0.018 DBMET03745 | DBMET03745 | |
| 0.01 | 0.235 | 0.044 | Angiotensin II receptor antagonist | 0.044 0.01 DBMET03745 | DBMET03745 | |
| 0.068 | 0.294 | 0.231 | Aldehyde oxidase inhibitor | 0.231 0.09 DBMET03745 | DBMET03745 | |
| 0.123 | 0.351 | 0.357 | Histamine release inhibitor | 0.357 0.097 DBMET03745 | DBMET03745 | |
| 0.108 | 0.345 | 0.211 | Vasodilator, coronary | 0.211 0.172 DBMET03745 | DBMET03745 | |
| 0.033 | 0.27 | 0.103 | Creatine kinase inhibitor | 0.103 0.056 DBMET03745 | DBMET03745 | |
| 0.009 | 0.253 | 0.053 | Angiotensin AT1 receptor antagonist | 0.053 0.014 DBMET03745 | DBMET03745 | |
| 0.153 | 0.4 | 0.313 | 5 Hydroxytryptamine release inhibitor | 0.313 0.151 DBMET03745 | DBMET03745 | |
| 0.029 | 0.28 | 0.079 | Glutamate dehydrogenase inhibitor | 0.079 0.046 DBMET03745 | DBMET03745 | |
| 0.017 | 0.269 | 0.049 | Aconitate hydratase inhibitor | 0.049 0.041 DBMET03745 | DBMET03745 | |
| 0.004 | 0.257 | 0.023 | Angiotensin-converting enzyme 2 inhibitor | 0.023 0.006 DBMET03745 | DBMET03745 | |
| 0.066 | 0.33 | 0.201 | Growth hormone agonist | 0.201 0.058 DBMET03745 | DBMET03745 | |
| 0.006 | 0.271 | 0.045 | Ribonucleoside-diphosphate reductase inhibitor | 0.045 0.044 DBMET03745 | DBMET03745 | |
| 0.009 | 0.285 | 0.035 | Toll-Like receptor 2 agonist | 0.035 0.034 DBMET03745 | DBMET03745 | |
| 0.061 | 0.338 | 0.145 | Hepatoprotectant | 0.145 0.115 DBMET03745 | DBMET03745 | |
| 0.037 | 0.325 | 0.108 | Alpha-N-acetylglucosaminidase inhibitor | 0.108 0.09 DBMET03745 | DBMET03745 | |
| 0.029 | 0.323 | 0.091 | Ferrochelatase inhibitor | 0.091 0.081 DBMET03745 | DBMET03745 | |
| 0.046 | 0.348 | 0.085 | Estrogen-related receptor beta agonist | 0.085 0.052 DBMET03745 | DBMET03745 | |
| 0.003 | 0.316 | 0.011 | Calcium-dependent phospholipase A2 inhibitor | 0.011 0.01 DBMET03745 | DBMET03745 | |
| 0.03 | 0.366 | 0.455 | Thrombolytic | 0.455 0.007 DBMET03745 | DBMET03745 | |
| 0.042 | 0.382 | 0.264 | Immunostimulant | 0.264 0.091 DBMET03745 | DBMET03745 | |
| 0.017 | 0.36 | 0.08 | Aminopeptidase I inhibitor | 0.08 0.042 DBMET03745 | DBMET03745 | |
| 0.023 | 0.392 | 0.092 | Aminopeptidase B inhibitor | 0.092 0.071 DBMET03745 | DBMET03745 | |
| 0.064 | 0.435 | 0.169 | Superoxide dismutase inhibitor | 0.169 0.157 DBMET03745 | DBMET03745 | |
| 0.038 | 0.416 | 0.234 | Hypolipemic | 0.234 0.075 DBMET03745 | DBMET03745 | |
| 0.028 | 0.422 | 0.127 | Bone formation stimulant | 0.127 0.079 DBMET03745 | DBMET03745 | |
| 0.044 | 0.447 | 0.195 | Succinate dehydrogenase inhibitor | 0.195 0.053 DBMET03745 | DBMET03745 | |
| 0.023 | 0.435 | 0.12 | Uric acid excretion stimulant | 0.12 0.038 DBMET03745 | DBMET03745 | |
| 0.006 | 0.439 | 0.094 | Peroxisome proliferator-activated receptor gamma agonist | 0.094 0.032 DBMET03745 | DBMET03745 | |
| 0.038 | 0.498 | 0.134 | Polo-like kinase-3 inhibitor | 0.134 0.104 DBMET03745 | DBMET03745 | |
| 0.034 | 0.553 | 0.184 | Cardiotonic | 0.184 0.135 DBMET03745 | DBMET03745 | |
| 0.003 | 0.551 | 0.038 | Sphingosine 1-phosphate receptor 1 agonist | 0.038 0.037 DBMET03745 | DBMET03745 | |
| 0.005 | 0.561 | 0.066 | Angiotensin-converting enzyme inhibitor | 0.066 0.023 DBMET03745 | DBMET03745 | |
| 0.004 | 0.608 | 0.04 | Sphingosine 1-phosphate receptor agonist | 0.04 0.037 DBMET03745 | DBMET03745 | |
| 0.036 | 0.695 | 0.41 | Cyclophilin D inhibitor | 0.41 0.086 DBMET03745 | DBMET03745 | |
| 0.017 | 0.68 | 0.143 | Insulin secretagoues | 0.143 0.082 DBMET03745 | DBMET03745 | |
| 0.041 | 0.717 | 0.271 | Apoptosis antagonist | 0.271 0.108 DBMET03745 | DBMET03745 | |
| 0.006 | 0.738 | 0.054 | Sphingosine 1-phosphate receptor 5 agonist | 0.054 0.036 DBMET03745 | DBMET03745 | |
| 0.012 | 0.754 | 0.115 | Cell adhesion inhibitor | 0.115 0.069 DBMET03745 | DBMET03745 | |
| 0.008 | 0.764 | 0.134 | Anticoagulant | 0.134 0.096 DBMET03745 | DBMET03745 | |
| 0.006 | 0.768 | 0.071 | Cell adhesion molecule inhibitor | 0.071 0.067 DBMET03745 | DBMET03745 | |
| 0.023 | 0.789 | 0.147 | Ca(v)3.1 blocker | 0.147 0.006 DBMET03745 | DBMET03745 | |
| 0.001 | 0.833 | 0.022 | Neutral endopeptidase inhibitor | 0.022 0.014 DBMET03745 | DBMET03745 | |
| 0.007 | 0.857 | 0.151 | Amyloid beta precursor protein antagonist | 0.151 0.1 DBMET03745 | DBMET03745 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |